Evidence map›Paper›PMID 21647274›Full record

ArticlePediatric reports2011

Laboratory aid to the diagnosis and therapy of infection in the neonate.

Gaetano Chirico, Cristina Loda

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Pediatric reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05985174 (Role of Neutrophil CD64 and Monocyte HLA-DR Markers in the Dignosis of Neonatal Sepsis), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.6field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05985174 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Role of Neutrophil CD64 and Monocyte HLA-DR Markers in the Dignosis of Neonatal Sepsis

TypeinterventionalSponsorSohag UniversityRan2023 to 2024Enrolled50ConditionsNeonatal SepsisArmsCD64 , HLA-DR
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. A decade of neonatal sepsis in Stockholm, Sweden: Gram-positive pathogens were four times as common as Gram-negatives.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  3. Article
  4. Article
  5. Tackling Neonatal Sepsis-Can It Be Predicted?International journal of environmental research and public health · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. The Association of Laboratory Test Abnormalities With Mortality Risk in Pediatric Intensive Care.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2021
    Article
  10. Article
  11. Article
  12. Precision Medicine for Neonatal Sepsis.Frontiers in molecular biosciences · 2018
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Gaetano ChiricoDepartment of Neonatology and Neonatal Intensive Care, Children Hospital, Spedali Civili, Brescia, Italy.
Cristina Loda
Institut Català d'Oncologia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the advances in perinatal and neonatal care and use of newer potent antibiotics, the incidence of neonatal sepsis remains high and the outcome is still severe. For years, investigators have sought a test or panel of tests able to identify septic neonates accurately and rapidly in order to obtain an early diagnosis and develop a specific effective treatment for a successful outcome. In addition to the standard procedures (blood, CSF, and urine cultures), such panels have included a combination of haematological investigations (total, differential and immature cell counts), and levels of acute-phase reactants (principally CRP and procalcitonin), and cytokines (such as IL-6 or neutrophil CD64). Furthermore, the science of proteomics and genomics has been applied to the search for bio-markers, production of protein profiles and genetic polymorphisms that can rapidly help the prediction, early diagnosis, and treatment of human diseases, but, for now, data are as yet insufficient to confirm their validity.

Indexed as

IgG antibodies.neonatal sepsis

Identifiers

PMID21647274
PMCPMC3103129
OpenAlexW2057362091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.